139 related articles for article (PubMed ID: 9093771)
1. Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus.
Nishiya K; Hashimoto K
Clin Exp Rheumatol; 1997; 15(1):39-44. PubMed ID: 9093771
[TBL] [Abstract][Full Text] [Related]
2. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus.
Lim MK; Lee CK; Ju YS; Cho YS; Lee MS; Yoo B; Moon HB
Rheumatol Int; 2001 Apr; 20(3):89-93. PubMed ID: 11354563
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus.
Beyan E; Beyan C; Demirezer A; Ertuğrul E; Uzuner A
Scand J Rheumatol; 2003; 32(4):225-8. PubMed ID: 14626629
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
[TBL] [Abstract][Full Text] [Related]
7. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(5):533-40. PubMed ID: 9779299
[TBL] [Abstract][Full Text] [Related]
8. Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus.
Skeith KJ; Wefuan J; Oswald R; Davis P
J Rheumatol; 1993 Aug; 20(8):1309-15. PubMed ID: 8230010
[TBL] [Abstract][Full Text] [Related]
9. Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.
Mok CC; Ding HH; Kharboutli M; Mohan C
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1303-9. PubMed ID: 26749069
[TBL] [Abstract][Full Text] [Related]
10. Increased Serum Levels of Anti-Carbamylated 78-kDa Glucose-Regulated Protein Antibody in Patients with Rheumatoid Arthritis.
Yu HC; Lai PH; Lai NS; Huang HB; Koo M; Lu MC
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618024
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity.
Houssiau FA; Lefebvre C; Vanden Berghe M; Lambert M; Devogelaer JP; Renauld JC
Lupus; 1995 Oct; 4(5):393-5. PubMed ID: 8563734
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
13. Serum oxidized low-density lipoproteins in rheumatoid arthritis.
Kim SH; Lee CK; Lee EY; Park SY; Cho YS; Yoo B; Moon HB
Rheumatol Int; 2004 Jul; 24(4):230-3. PubMed ID: 14628150
[TBL] [Abstract][Full Text] [Related]
14. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus.
Narumi S; Takeuchi T; Kobayashi Y; Konishi K
Cytokine; 2000 Oct; 12(10):1561-5. PubMed ID: 11023674
[TBL] [Abstract][Full Text] [Related]
16. The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus.
Son CN; Lee TH; Bang JH; Jeong HJ; Chae JN; Lee WM; Kim JM; Kim SH
Korean J Intern Med; 2018 Jul; 33(4):823-828. PubMed ID: 28352058
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin in rheumatoid arthritis and systemic lupus erythematous.
Tsai WJ; Liu HW; Yen JH; Chen JR; Lin SF; Chen TP
Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Jan; 7(1):22-6. PubMed ID: 1990149
[TBL] [Abstract][Full Text] [Related]
18. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders.
Stuart RA; Littlewood AJ; Maddison PJ; Hall ND
Clin Exp Rheumatol; 1995; 13(1):17-22. PubMed ID: 7774098
[TBL] [Abstract][Full Text] [Related]
20. Profiles of the acute-phase reactants C-reactive protein and ferritin related to the disease course of patients with systemic lupus erythematosus.
Hesselink DA; Aarden LA; Swaak AJ
Scand J Rheumatol; 2003; 32(3):151-5. PubMed ID: 12892251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
